NICE

Showing 15 posts of 868 posts found.

NICE image

NICE recommends Xgeva for bone metastasis

March 29, 2012
Sales and Marketing Amgen, NICE, Xgeva, Zytiga, denosumab, prostate cancer

NICE has issued draft guidance recommending Amgen’s Xgeva (denosumab) for certain groups of cancer patients whose disease has spread to …

NICE hq pic

NICE looking into unlicensed and off-label drug use

March 26, 2012
Sales and Marketing DoH, NICE, off label, off-label, postcode, unlicensed

NICE is reviewing the use of off-label and unlicensed medicines across the NHS in England. This follows a pilot project …

NICE image

NICE starts new wave of quality standards

March 22, 2012
Sales and Marketing Commissioning Board, Future Forum, NHS, NICE

NICE has been given 123 new quality standards to work on, and includes for the first time new standards for …

NICE guidance app

NICE launches new guidance app

March 20, 2012
Medical Communications, Sales and Marketing Android, Apple, NICE, app, digital, guidance

NICE has launched a new app that allows mobile access to all of NICE’s recommendations and advice of the past …

NICE recommends Incivo for hepatitis C

March 16, 2012
Sales and Marketing Incivo, Janssen, NICE, Victrelis, telaprevir

NICE is recommending Janssen’s hepatitis C pill Incivo for funding on the NHS in England. The drug has bypassed the …

Gilenya picture

NICE U-turn sees Gilenya MS pill recommended

March 16, 2012
Sales and Marketing MS, NICE, UK, fingolimod, gilenya

NICE has changed its mind on Novartis’ multiple sclerosis pill Gilenya, and is now recommending the drug in a subgroup …

Pradaxa image

NICE recommends Pradaxa for stroke prevention

March 15, 2012
Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation

NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …

Zytiga image

Charity attacks Scottish decision on Zytiga

March 14, 2012
Sales and Marketing Janssen, NICE, PAS, Prostate Cancer Charity, Zytiga

Scotland’s medicines regulator has turned down Janssen’s prostate cancer pill Zytiga, leading to a backlash from charities. The Scottish Medicines …

Zelboraf image

Roche’s melanoma pill launched in UK

March 14, 2012
Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf

Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer.  Zelboraf (vemurafenib) is the …

Xarelto picture

NICE wants more information on Xarelto

March 13, 2012
Sales and Marketing Bayer, DVT, NICE, Xarelto

NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance.  The watchdog is currently minded …

Victrelis picture

NICE recommends Victrelis in speedy review

March 9, 2012
Sales and Marketing Incivo, Janssen, Merck, NICE, Pegasus, Victrelis

NICE is recommending Merck’s hepatitis C pill Victrelis for funding in the NHS, in an expedited review.  In its final …

Zytiga image

Cancer Drugs Fund should not be used across the UK

March 7, 2012
Sales and Marketing CDF, Janssen, NICE, Zytiga, myloma, prostate

The Prostate Cancer Charity has said that extending England’s Cancer Drugs Fund to the UK will not solve the issue …

mark_baker_photograph2

NICE appoints two new directors

March 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Baker, NICE

The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …

Sir David Nicholson

Doctors don’t want rationing responsibility, finds survey

February 28, 2012
Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing

 A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …

Witty hits out at ‘systematic delays’ to medicines

February 27, 2012
Sales and Marketing Europe, GSK, NICE, austerity

 GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …

The Gateway to Local Adoption Series

Latest content